150 related articles for article (PubMed ID: 33236637)
21. Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.
Cadavid-Vargas JF; Leon IE; Etcheverry SB; Santi E; Torre MH; Di Virgilio AL
Anticancer Agents Med Chem; 2017; 17(3):424-433. PubMed ID: 27173967
[TBL] [Abstract][Full Text] [Related]
22. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models.
Sanz Del Olmo N; Carloni R; Bajo AM; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
Nanoscale; 2019 Jul; 11(28):13330-13342. PubMed ID: 31271405
[TBL] [Abstract][Full Text] [Related]
23. Ruthenium dendrimers against acute promyelocytic leukemia:
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Abashkin V; Dzmitruk V; Rogalska A; Denel M; Gapinska M; Shcharbin D; Gomez Ramirez R; de la Mata FJ; Bryszewska M
Future Med Chem; 2019 Jul; 11(14):1741-1756. PubMed ID: 31287722
[TBL] [Abstract][Full Text] [Related]
24. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications.
Kalomiraki M; Thermos K; Chaniotakis NA
Int J Nanomedicine; 2016; 11():1-12. PubMed ID: 26730187
[TBL] [Abstract][Full Text] [Related]
25. Phosphorus Dendrimers as Nanotools against Cancers.
Caminade AM
Molecules; 2020 Jul; 25(15):. PubMed ID: 32708025
[TBL] [Abstract][Full Text] [Related]
26. In Vitro Anticancer Properties of Copper Metallodendrimers.
Hołota M; Magiera J; Michlewska S; Kubczak M; Del Olmo NS; García-Gallego S; Ortega P; de la Mata FJ; Ionov M; Bryszewska M
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31003561
[TBL] [Abstract][Full Text] [Related]
27. Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity.
Sanz Del Olmo N; Maroto-Díaz M; Gómez R; Ortega P; Cangiotti M; Ottaviani MF; de la Mata FJ
J Inorg Biochem; 2017 Dec; 177():211-218. PubMed ID: 29031179
[TBL] [Abstract][Full Text] [Related]
28. Safe Polycationic Dendrimers as Potent Oral In Vivo Inhibitors of
Mignani S; Tripathi VD; Soam D; Tripathi RP; Das S; Singh S; Gandikota R; Laurent R; Karpus A; Caminade AM; Steinmetz A; Dasgupta A; Srivastava KK; Majoral JP
Biomacromolecules; 2021 Jun; 22(6):2659-2675. PubMed ID: 33970615
[TBL] [Abstract][Full Text] [Related]
29. Crown Macromolecular Derivatives: Stepwise Design of New Types of Polyfunctionalized Phosphorus Dendrimers.
Karpus A; Mignani S; Zablocka M; Majoral JP
J Org Chem; 2022 Mar; 87(5):3433-3441. PubMed ID: 35142502
[TBL] [Abstract][Full Text] [Related]
30. Prednisone and ibuprofen conjugate Janus dendrimers and their anticancer activity.
Barajas-Mendoza I; Castillo-Rodríguez IO; Hernández-Rioja I; Ramirez-Apan T; Martínez-García M
Steroids; 2024 May; 205():109395. PubMed ID: 38461962
[TBL] [Abstract][Full Text] [Related]
31. Fluorescent Phosphorus Dendrimer as a Spectral Nanosensor for Macrophage Polarization and Fate Tracking in Spinal Cord Injury.
Shakhbazau A; Mishra M; Chu TH; Brideau C; Cummins K; Tsutsui S; Shcharbin D; Majoral JP; Mignani S; Blanchard-Desce M; Bryszewska M; Yong VW; Stys PK; van Minnen J
Macromol Biosci; 2015 Nov; 15(11):1523-34. PubMed ID: 26175127
[TBL] [Abstract][Full Text] [Related]
32. Phosphorus-carrying cascade molecules: inner architecture to biomedical applications.
Thirumalai A; Elboughdiri N; Harini K; Girigoswami K; Girigoswami A
Turk J Chem; 2023; 47(4):667-688. PubMed ID: 38174062
[TBL] [Abstract][Full Text] [Related]
33. Interactions of Nitroxide-Conjugated and Non-Conjugated Glycodendrimers with Normal and Cancer Cells and Biocompatibility Studies.
Andreozzi E; Antonelli A; Cangiotti M; Canonico B; Sfara C; Pianetti A; Bruscolini F; Sahre K; Appelhans D; Papa S; Ottaviani MF
Bioconjug Chem; 2017 Feb; 28(2):524-538. PubMed ID: 28068077
[TBL] [Abstract][Full Text] [Related]
34. Phosphorus dendrimers functionalised with nitrogen ligands, for catalysis and biology.
Caminade AM; Majoral JP
Dalton Trans; 2019 Jun; 48(22):7483-7493. PubMed ID: 31062819
[TBL] [Abstract][Full Text] [Related]
35. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
Uram Ł; Filipowicz A; Misiorek M; Pieńkowska N; Markowicz J; Wałajtys-Rode E; Wołowiec S
Eur J Pharm Sci; 2018 Nov; 124():1-9. PubMed ID: 30118847
[TBL] [Abstract][Full Text] [Related]
36. Design considerations for PAMAM dendrimer therapeutics.
Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in dendrimer-based nanomedicine development.
Kim Y; Park EJ; Na DH
Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
[TBL] [Abstract][Full Text] [Related]
38. Anticancer Activity of Water-Soluble Olsalazine-PAMAM-Dendrimer-Salicylic Acid-Conjugates.
Cortez-Maya S; Pedro-Hernández LD; Martínez-Klimova E; Ramírez-Ápan T; Martínez-García M
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31412571
[TBL] [Abstract][Full Text] [Related]
39. Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization.
Galan M; Sanchez-Rodriguez J; Cangiotti M; Garcia-Gallego S; Jimenez JL; Gomez R; Ottaviani MF; Munoz-Fernandez MA; de la Mata FJ
Curr Med Chem; 2012; 19(29):4984-94. PubMed ID: 22963631
[TBL] [Abstract][Full Text] [Related]
40. In vitro PAMAM, phosphorus and viologen-phosphorus dendrimers prevent rotenone-induced cell damage.
Milowska K; Szwed A; Zablocka M; Caminade AM; Majoral JP; Mignani S; Gabryelak T; Bryszewska M
Int J Pharm; 2014 Oct; 474(1-2):42-9. PubMed ID: 25108046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
